2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer PatientsBody Weight, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, atypical endometrial hyperplasia, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, nutritional disorder, obesity disorder, overnutrition, progesterone resistance, uterine disorderRecruitingPhase 2 / Phase 32026-09-10NCT06379113
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia PatientsBody Weight, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, atypical endometrial hyperplasia, female reproductive system disorder, nutritional disorder, obesity disorder, overnutrition, progesterone resistance, uterine disorderActive, not recruitingPhase 2 / Phase 32025-08-11NCT06390904